HeartCore Enterprises, Inc. (HTCR)
After hours:
| Previous close | 0.8308 |
| Open | 0.7980 |
| Bid | 0.5740 x 200 |
| Ask | 1.0300 x 200 |
| Day's range | 0.7773 - 0.8101 |
| 52-week range | 0.3600 - 3.4300 |
| Volume | |
| Avg. volume | 61,184 |
| Market cap | 16.218M |
| Beta (5Y monthly) | 1.67 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.2100 |
| Earnings date | N/A |
| Forward dividend & yield | 0.08 (10.29%) |
| Ex-dividend date | 25 Apr 2024 |
| 1y target est | N/A |
GlobeNewswireHeartCore Reports First Quarter 2024 Financial Results
NEW YORK and TOKYO, May 14, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and consulting services company based in Tokyo, reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 and Recent Operational Highlights Sold a Go IPO Client Warrant for $9 million. During the first quarter ended March 31, 2024, the Company received $5 million, with the remaining $4 million received in Apr
- GlobeNewswire
HeartCore Provides Update on March Go IPO Warrant Sale and Encouraging Outlook
NEW YORK and TOKYO, May 13, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced updates around the previously announced sale of a Go IPO warrant. In March 2024, HeartCore announced the sale of a Go IPO client’s warrant to a Japanese financial institution for $9 million. During the first quarter ended March 31, 2024, $5 million was received, with the remaining $4
- GlobeNewswire
HeartCore Expands Partnership with Heart-Tech Health
NEW YORK and TOKYO, April 22, 2024 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced its Artificial Intelligence (AI) Software Development Division (“AI Division”) has engaged with Heart-Tech Health to implement AI capabilities into its Med-Tech platform. Heart-Tech Health offers a suite of SaaS solutions designed to identify women’s cardiovascular risks at an earl
